http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9722347-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10bf03ed79de81dd1b55bc0e9b79a99e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef69863a5c0821e9e2f570c5cb42b554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d83198bc2e3204742b5c564869d7b458
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
filingDate 1996-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743851c71f05bd815a07329ee9ea3a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52fdf8de97e054edc97f9bc72fad596b
publicationDate 1997-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9722347-A1
titleOfInvention Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
abstract Dextran sulphate is used to potentiate C1-esterase inhibitor selectively with respect to inhibition of complement and coagulation, but not with respect to inhibition of the contact and fibrinolytic systems. The C1-esterase inhibitor to be potentiated by the dextran sulphate may be endogenous C1-esterase inhibitor, or exogenous C1-esterase inhibitor which is to be administered together with or separate from the dextran sulphate. Use of the dextran sulphate, alone or together with C1-esterase inhibitor, in prophylactic or therapeutic treatment of inflammatory conditions, such as sepsis and myocardial infarction.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10478451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035802-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10080788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130690-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015054569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364288-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105423-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616111-B2
priorityDate 1995-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9105566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0473564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9222320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8805301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4227762-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0293826-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0276370-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234204012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227851490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127897641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22815042

Total number of triples: 67.